Therapeutic potential of TRPM8 antagonists in prostate cancer
Abstract Transient receptor potential melastatin-8 (TRPM8) represents an emerging target in prostate cancer, although its mechanism of action remains unclear. Here, we have characterized and investigated the effects of TRPM8 modulators in prostate cancer aggressiveness disclosing the molecular mecha...
Guardado en:
Autores principales: | Marzia Di Donato, Carmine Ostacolo, Pia Giovannelli, Veronica Di Sarno, Isabel M. Gomez Monterrey, Pietro Campiglia, Antimo Migliaccio, Alessia Bertamino, Gabriella Castoria |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/fa3e2cc22ff64f05950e4e504372fb1e |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Communication between cells: exosomes as a delivery system in prostate cancer
por: Pia Giovannelli, et al.
Publicado: (2021) -
Androgen-induced cell migration: role of androgen receptor/filamin A association.
por: Gabriella Castoria, et al.
Publicado: (2011) -
Effect of small molecules modulating androgen receptor (SARMs) in human prostate cancer models.
por: Anna Tesei, et al.
Publicado: (2013) -
TRPM6 and TRPM7 differentially contribute to the relief of heteromeric TRPM6/7 channels from inhibition by cytosolic Mg2+ and Mg·ATP
por: Silvia Ferioli, et al.
Publicado: (2017) -
Extracellular Vesicles in Osteosarcoma: Antagonists or Therapeutic Agents?
por: Viviana De Martino, et al.
Publicado: (2021)